PMAM
CPRX

Picton Mahoney Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Picton Mahoney Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36K Hold
55
– – ﹤0.01% 1089
2025
Q4 		$1.28K Hold
55
– – ﹤0.01% 1040
2025
Q3 		$1K Hold
55
– – ﹤0.01% 900
2025
Q2 		$1K Hold
55
– – ﹤0.01% 779
2025
Q1 		$1K Hold
55
– – ﹤0.01% 753
2024
Q4 		$1K Hold
55
– – ﹤0.01% 647
2024
Q3 		$1K Buy
+55
New +$1.02K ﹤0.01% 639

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Picton Mahoney Asset Management's CPRX Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2026 at 55 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Picton Mahoney Asset Management first reported a position in CPRX in Q3 2024 and has held it in 7 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Picton Mahoney Asset Management held 55 shares of Catalyst Pharmaceutical worth $1.36K as of Q1 2026.
  • Picton Mahoney Asset Management left its Catalyst Pharmaceutical share count unchanged in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1089 holding.
  • Picton Mahoney Asset Management first reported a position in Catalyst Pharmaceutical in Q3 2024 and has held it in 7 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.